PUMA BIOTECHNOLOGY, INC. Stock Issued During Period, Value, Employee Stock Purchase Plan
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-06-30 was $0.00, a 100.00% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2026-03-31 was $0.00.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-12-31 was $0.00.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, employee stock purchase plan for the quarter ending 2025-09-30 was $0.00, a 100.00% decline year-over-year.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, employee stock purchase plan for fiscal 2025 was $130.00K, a 13.33% decline from fiscal 2024.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, employee stock purchase plan for fiscal 2024 was $150.00K.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, employee stock purchase plan for fiscal 2023 was $0.00.
- PUMA BIOTECHNOLOGY, INC. stock issued during period, value, employee stock purchase plan for fiscal 2022 was $0.00.
| Period end | Stock Issued During Period, Value, Employee Stock Purchase Plan 3 month | Stock Issued During Period, Value, Employee Stock Purchase Plan 12 month |
|---|---|---|
| 2026-06-30 | $0.00 10-Q · filed 2026-08-06 | $0.00 derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $0.00 10-Q · filed 2026-05-07 | $130.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $130.00K 10-K · filed 2026-02-26 |
| 2025-09-30 | $0.00 10-Q · filed 2025-11-06 | $130.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $130.00K 10-Q · filed 2026-08-06 | $280.00K derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $0.00 10-Q · filed 2026-05-07 | $150.00K derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $150.00K 10-K · filed 2026-02-26 |
| 2024-09-30 | $150.00K 10-Q · filed 2025-11-06 | $150.00K derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-07 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-08 | $0.00 derived: sum of 4 quarters · filed 2026-02-26 |
| 2023-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-26 | $0.00 10-K · filed 2026-02-26 |
| 2023-09-30 | $0.00 10-Q · filed 2024-11-07 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | $0.00 10-Q · filed 2024-08-01 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | $0.00 10-Q · filed 2024-05-02 | $0.00 derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | $0.00 10-K · filed 2025-02-27 |
| 2022-09-30 | $0.00 10-Q · filed 2023-11-02 | $0.00 derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-06-30 | $0.00 10-Q · filed 2023-08-03 | $0.00 derived: sum of 4 quarters · filed 2024-02-29 |
| 2022-03-31 | $0.00 10-Q · filed 2023-05-04 | $0.00 derived: sum of 4 quarters · filed 2024-02-29 |
| 2021-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-29 | $0.00 10-K · filed 2024-02-29 |
| 2021-09-30 | $0.00 10-Q · filed 2022-11-03 | $23.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-06-30 | $0.00 10-Q · filed 2022-08-04 | $66.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2021-03-31 | $0.00 10-Q · filed 2022-05-05 | $68.00K derived: sum of 4 quarters · filed 2023-03-02 |
| 2020-12-31 | $23.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-02 | $68.00K 10-K · filed 2023-03-02 |
| 2020-09-30 | $43.00K 10-Q · filed 2021-11-04 | |
| 2020-06-30 | $2.00K 10-Q · filed 2021-08-05 | |
| 2019-12-31 | -$1.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-03 | $1.35M 10-K · filed 2022-03-03 |
| 2019-09-30 | $76.00K 10-Q · filed 2020-11-05 | $1.85M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-06-30 | $194.00K 10-Q · filed 2020-08-06 | $2.79M derived: sum of 4 quarters · filed 2021-03-01 |
| 2019-03-31 | $1.08M 10-Q · filed 2020-05-07 | $5.59M derived: sum of 4 quarters · filed 2021-03-01 |
| 2018-12-31 | $501.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-01 | $7.65M 10-K · filed 2021-03-01 |
| 2018-09-30 | $1.01M 10-Q · filed 2019-11-07 | |
| 2018-06-30 | $2.99M 10-Q · filed 2019-08-09 | |
| 2018-03-31 | $3.15M 10-Q · filed 2019-05-10 | |
| 2017-12-31 | $26.68M 10-K · filed 2020-02-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |